跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zartan Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zartan Plus
Approved
STANDARD
Zartan Plus
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
349e3ab2b8216c3b
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
349e3ab2b8216c3b
Drug Approval Philippines Name
Zartan Plus
Product Name
Zartan Plus
Registration Number
DRP-2669-02
Brand Name
Zartan Plus
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg / 12.5 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
Sigmamatic Co. Inc.
Issuance Date
26 November 2020
Expiry Date
03 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
349e3ab2b8216c3b
Type
Standard
Back to Philippines FDA Approvals